CorAssist Cardiovascular

CorAssist Cardiovascular is a medical device company dedicated to developing novel treatments for diastolic heart failure, specifically Heart Failure with preserved Ejection Fraction (HFpEF). The company's primary technology, the CORolla device, is an elastic, spring-like implant designed to be inserted into the left ventricle to improve diastolic filling by applying an outward force during the heart's relaxation phase. This approach addresses the unmet clinical need of patients whose heart muscle has become stiff and cannot fill properly with blood. CorAssist's devices are designed for minimally invasive delivery, offering a potential therapeutic option for a large patient population with limited treatment alternatives.